Annual EBIT
-$38.67 M
-$13.56 M-54.01%
December 31, 2023
Summary
- As of February 12, 2025, SLNO annual earnings before interest & taxes is -$38.67 million, with the most recent change of -$13.56 million (-54.01%) on December 31, 2023.
- During the last 3 years, SLNO annual EBIT has fallen by -$6.72 million (-21.04%).
- SLNO annual EBIT is now -4465.53% below its all-time high of -$847.00 thousand, reached on December 31, 2013.
Performance
SLNO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$79.33 M
-$56.10 M-241.50%
September 30, 2024
Summary
- As of February 12, 2025, SLNO quarterly earnings before interest & taxes is -$79.33 million, with the most recent change of -$56.10 million (-241.50%) on September 30, 2024.
- Over the past year, SLNO quarterly EBIT has dropped by -$69.97 million (-747.51%).
- SLNO quarterly EBIT is now -4150.39% below its all-time high of $1.96 million, reached on March 31, 2013.
Performance
SLNO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$138.47 M
-$69.97 M-102.16%
September 30, 2024
Summary
- As of February 12, 2025, SLNO TTM earnings before interest & taxes is -$138.47 million, with the most recent change of -$69.97 million (-102.16%) on September 30, 2024.
- Over the past year, SLNO TTM EBIT has dropped by -$106.42 million (-332.00%).
- SLNO TTM EBIT is now -7169.43% below its all-time high of $1.96 million, reached on March 31, 2013.
Performance
SLNO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SLNO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.0% | -747.5% | -332.0% |
| 3 y3 years | -21.0% | -747.5% | -332.0% |
| 5 y5 years | -181.6% | -747.5% | -332.0% |
SLNO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.0% | at low | -1199.9% | at low | -451.5% | at low |
| 5 y | 5-year | -66.7% | at low | -1199.9% | at low | -496.9% | at low |
| alltime | all time | -4465.5% | at low | -4150.4% | at low | -7169.4% | at low |
Soleno Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$79.33 M(+241.5%) | -$138.47 M(+102.2%) |
| Jun 2024 | - | -$23.23 M(+0.7%) | -$68.50 M(+27.9%) |
| Mar 2024 | - | -$23.07 M(+79.9%) | -$53.57 M(+38.5%) |
| Dec 2023 | -$38.67 M(+54.0%) | -$12.83 M(+37.0%) | -$38.67 M(+20.6%) |
| Sep 2023 | - | -$9.36 M(+12.6%) | -$32.05 M(+11.3%) |
| Jun 2023 | - | -$8.31 M(+1.7%) | -$28.80 M(+8.1%) |
| Mar 2023 | - | -$8.17 M(+31.5%) | -$26.65 M(+6.1%) |
| Dec 2022 | -$25.11 M(-22.2%) | -$6.21 M(+1.8%) | -$25.11 M(-0.5%) |
| Sep 2022 | - | -$6.10 M(-1.0%) | -$25.23 M(-6.1%) |
| Jun 2022 | - | -$6.16 M(-7.1%) | -$26.86 M(-6.6%) |
| Mar 2022 | - | -$6.63 M(+4.8%) | -$28.75 M(-10.9%) |
| Dec 2021 | -$32.26 M(+1.0%) | -$6.33 M(-18.2%) | -$32.26 M(-4.4%) |
| Sep 2021 | - | -$7.74 M(-3.9%) | -$33.75 M(+2.0%) |
| Jun 2021 | - | -$8.05 M(-20.6%) | -$33.09 M(-0.9%) |
| Mar 2021 | - | -$10.14 M(+29.8%) | -$33.39 M(+4.5%) |
| Dec 2020 | -$31.95 M(+37.7%) | -$7.82 M(+10.4%) | -$31.95 M(+3.0%) |
| Sep 2020 | - | -$7.08 M(-15.2%) | -$31.01 M(+3.3%) |
| Jun 2020 | - | -$8.35 M(-4.0%) | -$30.03 M(+10.7%) |
| Mar 2020 | - | -$8.70 M(+26.4%) | -$27.12 M(+16.9%) |
| Dec 2019 | -$23.20 M(+68.9%) | -$6.88 M(+12.7%) | -$23.20 M(+16.7%) |
| Sep 2019 | - | -$6.11 M(+12.2%) | -$19.87 M(+14.1%) |
| Jun 2019 | - | -$5.44 M(+14.0%) | -$17.42 M(+12.7%) |
| Mar 2019 | - | -$4.77 M(+34.2%) | -$15.46 M(+12.6%) |
| Dec 2018 | -$13.73 M | -$3.56 M(-2.5%) | -$13.73 M(-14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$3.65 M(+4.9%) | -$16.06 M(+6.8%) |
| Jun 2018 | - | -$3.48 M(+14.2%) | -$15.04 M(+3.5%) |
| Mar 2018 | - | -$3.05 M(-48.2%) | -$14.53 M(+13.0%) |
| Dec 2017 | -$12.85 M(+54.4%) | -$5.88 M(+123.5%) | -$12.85 M(+46.0%) |
| Sep 2017 | - | -$2.63 M(-11.4%) | -$8.81 M(+8.1%) |
| Jun 2017 | - | -$2.97 M(+116.2%) | -$8.14 M(+9.0%) |
| Mar 2017 | - | -$1.37 M(-25.1%) | -$7.47 M(-27.9%) |
| Dec 2016 | -$8.32 M(-31.5%) | -$1.83 M(-6.9%) | -$10.36 M(+35.9%) |
| Sep 2016 | - | -$1.97 M(-14.2%) | -$7.62 M(-14.8%) |
| Jun 2016 | - | -$2.29 M(-46.2%) | -$8.95 M(-7.7%) |
| Mar 2016 | - | -$4.26 M(-571.9%) | -$9.70 M(+23.4%) |
| Dec 2015 | -$12.16 M(+33.5%) | $903.30 K(-127.4%) | -$7.86 M(-46.0%) |
| Sep 2015 | - | -$3.29 M(+8.2%) | -$14.56 M(+15.7%) |
| Jun 2015 | - | -$3.04 M(+25.5%) | -$12.59 M(+16.0%) |
| Mar 2015 | - | -$2.43 M(-58.1%) | -$10.85 M(+22.3%) |
| Dec 2014 | -$9.11 M(+975.2%) | -$5.79 M(+337.9%) | -$8.87 M(+137.1%) |
| Sep 2014 | - | -$1.32 M(+1.2%) | -$3.74 M(+8.8%) |
| Jun 2014 | - | -$1.31 M(+193.0%) | -$3.44 M(+3.2%) |
| Mar 2014 | - | -$446.00 K(-32.8%) | -$3.33 M(+259.6%) |
| Dec 2013 | -$847.00 K(-76.6%) | -$664.00 K(-34.8%) | -$926.20 K(+253.2%) |
| Sep 2013 | - | -$1.02 M(-15.2%) | -$262.20 K(-134.6%) |
| Jun 2013 | - | -$1.20 M(-161.4%) | $756.80 K(-61.4%) |
| Mar 2013 | - | $1.96 M | $1.96 M |
| Dec 2012 | -$3.62 M | - | - |
FAQ
- What is Soleno Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Soleno Therapeutics?
- What is Soleno Therapeutics annual EBIT year-on-year change?
- What is Soleno Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly EBIT year-on-year change?
- What is Soleno Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Soleno Therapeutics?
- What is Soleno Therapeutics TTM EBIT year-on-year change?
What is Soleno Therapeutics annual earnings before interest & taxes?
The current annual EBIT of SLNO is -$38.67 M
What is the all time high annual EBIT for Soleno Therapeutics?
Soleno Therapeutics all-time high annual earnings before interest & taxes is -$847.00 K
What is Soleno Therapeutics annual EBIT year-on-year change?
Over the past year, SLNO annual earnings before interest & taxes has changed by -$13.56 M (-54.01%)
What is Soleno Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SLNO is -$79.33 M
What is the all time high quarterly EBIT for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly earnings before interest & taxes is $1.96 M
What is Soleno Therapeutics quarterly EBIT year-on-year change?
Over the past year, SLNO quarterly earnings before interest & taxes has changed by -$69.97 M (-747.51%)
What is Soleno Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SLNO is -$138.47 M
What is the all time high TTM EBIT for Soleno Therapeutics?
Soleno Therapeutics all-time high TTM earnings before interest & taxes is $1.96 M
What is Soleno Therapeutics TTM EBIT year-on-year change?
Over the past year, SLNO TTM earnings before interest & taxes has changed by -$106.42 M (-332.00%)